• Children Psoriasis
    • Emmanuel Mahé
    • Emmanuel Mahé: Influence Statistics

      Emmanuel Mahé

      Emmanuel Mahé

      Dermatology Department, Centre Hospitalier (CH), Argenteuil, France | Hôpital Victor Dupouy, Dermatologie, Argenteuil, France | Service de Dermatologie, Hôpital Victor Dupouy, ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Emmanuel Mahé:Expert Impact

      Concepts for whichEmmanuel Mahéhas direct influence:Children psoriasis,Onset psoriasis,Drug survival,Pyoderma gangrenosum,Psoriasis children,Psoriasis severity,Severe psoriasis,Simplified psoriasis.

      Emmanuel Mahé:KOL impact

      Concepts related to the work of other authors for whichfor which Emmanuel Mahé has influence:Atopic dermatitis,Skin cancer,Pediatric psoriasis,Drug reaction,Systemic symptoms,Psoriatic arthritis,Subcutaneous fat necrosis.

      KOL Resume for Emmanuel Mahé


      Dermatology Department, Centre Hospitalier (CH), Argenteuil, France


      Service De Dermatologie Et Médecine Vasculaire, Hôpital Victor Dupouy, Argenteuil, France.

      Department of Dermatology, Hospital of Argenteuil, Argenteuil, France


      Service de dermatologie, hôpital Victor-Dupouy, 69, rue du Lieutenant-Colonel Prud’hon, 95100 Argenteuil, France

      Dermatologie, Hôpital Victor Dupouy, Argenteuil

      Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, Paris


      Service de Dermatologie, Hôpital Victor Dupouy, 69 rue du Lieutenant-Colonel Prud’hon, 95100, Argenteuil, France


      Service de dermatologie et médecine vasculaire, hôpital Victor Dupouy, 69, rue du Lieutenant-Colonel Prud'hon, 95100 Argenteuil, France.

      Department of Dermatology, Centre Hospitalier Argenteuil, Argenteuil, France


      Dermatology Department, Hospital Victor Dupouy, Argenteuil, France

      Dermatologie, centre hospitalier Argenteuil


      Service de dermatologie, hôpital Victor-Dupouy, 69, rue du Lieutenant-Colonel-Prud’hon, 95107 Argenteuil, France


      Service de Dermatologie, Hôpital Victor Dupouy, 69 rue du Lieutenant‐Colonel Prud'hon, 95100, Argenteuil, France

      Dermatologie, Centre Hospitalier de Victor-Dupouy, Argenteuil


      Service de dermatologie, hôpital Victor-Dupouy, 69, rue du Lieutenant-Colonel-Prudhon, 95100 Argenteuil, France. Electronic address:

      Dermatologie, CHI d’Argenteuil, Argenteuil, France


      Dermatologie, Centre Hospitalier Victor-Dupouy, Argenteuil, France


      Department of Dermatology, Ambroise Paré University Hospital, University of Versailles‐Saint Quentin en Yvelines, Assistance Publique‐Hôpitaux de Paris, Boulogne‐Billancourt, France

      Research Unit EA 4339 “Skin, cancer, and environment”


      Dermatologie, hôpital Victor-Dupouy, Argenteuil, France

      Research Unit EA 4339 ‘Skin, Cancer and Environment’

      Sample of concepts for which Emmanuel Mahé is among the top experts in the world.
      Concept World rank
      life‐threatening cases #1
      drug survival obese #1
      covid‐19 lesions #1
      children publications #1
      palpébral induit #1
      new topical associations #1
      tattooing complications #1
      hospital nurses doctor #1
      crusted lesions treatment #1
      adalimumabinduced emn #1
      antiseptics medical prescription #1
      lesions life‐threatening cases #1
      severe pain hypercalcaemia #1
      patient start #1
      relapse proactive approach #1
      small patients series #1
      atteints psoriasis #1
      propos cas frequency #1
      non‐treated psoriatic #1
      nonobese patients ust #1
      chv ucsa #1
      single weekly dosage #1
      child psoriasis #1
      ucsa #1
      mucosal involvement treatment #1
      nurses chronic wounds #1
      antiseptics nurses #1
      photoprotection maximale #1
      chv departments #1
      oedema pruritus #1
      france children #1
      prescriptions water #1
      etiology treatment prognosis #1
      increment psoriatic #1
      pédiatrie hospitalière #1
      weight increment #1
      wounds super #1
      covid‐19 testing child #1
      supradiaphragmatic adenomegalies #1
      60 80 nurses #1
      children sfn #1
      obesity proactive #1
      flareups quality #1

      Prominent publications by Emmanuel Mahé

      KOL-Index: 16304

      BACKGROUND: Scabies is a frequent condition seen in infants and children. Only topical treatments have been approved in infants, but some of them are poorly tolerated. Oral ivermectin is approved for the treatment of scabies in several countries, but its use in infants and children weighing < 15 kg is off label.

      OBJECTIVES: To assess the safety of ivermectin in infants and young children, and to collect data on ivermectin efficacy in these age groups.

      METHODS: This study was performed in ...

      Known for Scabies Infants | Ivermectin Children | Oral Administration | Weighing 15 | Topical Treatment
      KOL-Index: 12310

      INTRODUCTION: Several studies have shown a high prevalence of cardiovascular and metabolic comorbidities in psoriasis. Our study aimed to evaluate the association of psoriasis with key comorbidities such as smoking, obesity, hypertension, dyslipidaemia and diabetes comparatively with French national data.

      MATERIAL AND METHODS: This multicentre noninterventional observational study of adults with psoriasis was conducted in 29 dermatology centres in France. A total of 2210 patients were ...

      Known for Psoriasis Patients | Prevalence Comorbidities | Obesity Hypertension | Age Onset | Psoriatic Arthritis
      KOL-Index: 11861

      BACKGROUND: Few prospective studies are available on the incidence and analysis of the characteristics of adverse cutaneous drug reactions in hospital settings.

      OBJECTIVES: A 6-month prospective study was managed in our hospital among hospitalized patients to: (i) evaluate the incidence of cutaneous allergic reactions from systemic drugs; (ii) study characteristics of patients with cutaneous drug reactions; (iii) describe the adverse cutaneous reactions; and (iv) evaluate drug reaction ...

      Known for Drug Reactions | Hospitalized Patients | Adverse Cutaneous | 15 Cases | Hospital Setting
      KOL-Index: 10400

      BACKGROUND: Psoriasis is associated with higher prevalences of cardiovascular and metabolic comorbidities in adults but the relationship of age at onset and those prevalences is unknown.

      OBJECTIVE: To evaluate whether the childhood onset of psoriasis (COP) is correlated with the frequency of cardiovascular and metabolic comorbidities in adulthood.

      METHODS: This noninterventional, cross-sectional, multicentre study of adults with psoriasis was conducted in 29 dermatology centres in ...

      Known for Onset Psoriasis | Metabolic Comorbidities | Dyslipidaemia Diabetes | Waist Circumference | Cardiovascular Risk
      KOL-Index: 9853

      BACKGROUND: Dupilumab is the first biologic available to treat atopic dermatitis (AD). Its effectiveness and safety were demonstrated in clinical trials.

      OBJECTIVE: We sought to assess the effectiveness and safety of dupilumab in adults with AD in a real-life French multicenter retrospective cohort.

      METHODS: We included patients treated during March 2017-April 2018. Efficacy outcomes, including Scoring Atopic Dermatitis (SCORAD) and Eczema Area and Severity Index (EASI) scores, were ...

      Known for Atopic Dermatitis | Monoclonal Antibodies | Safety Dupilumab | Adult Cohort | 3 Months
      KOL-Index: 9790

      BACKGROUND: Psoriasis is a T-cell-mediated immunological disease characterized by epidermal proliferation. The nature of the antigen(s) responsible for T-cell activation is still unknown. It has been suggested that the human papillomaviruses (HPVs) associated with epidermodysplasia verruciformis (EV), including the oncogenic HPV5, may contribute to the pathogenesis of psoriasis.

      OBJECTIVES: To determine whether EV-HPVs may play a role early in the disease, we searched for these viruses ...

      Known for Epidermodysplasia Verruciformis | Human Papillomaviruses | Atopic Dermatitis | Hpv5 Hpv36 | Pathogenesis Psoriasis
      KOL-Index: 9235

      BACKGROUND: Sirolimus is an immunosuppressive drug recently developed for organ transplantation. Its mechanism of action, independent of calcineurin, is different from that of cyclosporine and tacrolimus, two calcineurin inhibitors (CIs). Because the toxicity of CIs is partly the result of calcineurin blockade, sirolimus exhibits a different toxicity profile. In this study, we evaluated the profile, frequency, and severity of cutaneous adverse events in renal transplant recipients ...

      Known for Renal Transplant Recipients | Cutaneous Adverse Events | Receiving Sirolimus | Immunosuppressive Agents Kidney | Organ Transplantation
      KOL-Index: 9121

      BACKGROUND: Obesity is more common in adults with psoriasis than in the general population, but there is a lack of data available regarding this association in children.

      OBJECTIVES: To evaluate whether obesity was more common in French children with psoriasis of any clinical type or severity.

      METHODS: A multicentre case-control study was performed in 23 French dermatology centres. Children without chronic or genetic inflammatory disease were selected as controls and matched for age, sex ...

      Known for Children Psoriasis | Multicentre Study | Overweight Obesity | Chronic Disease | Clinical Type
      KOL-Index: 9121

      BACKGROUND: Excessive ultraviolet (UV) radiation exposure can cause skin cancers, skin photoageing and cataracts. Children are targeted by sun-protection campaigns because high sun exposure and sunburn in childhood increase the risk of melanoma in adulthood. Little information is available about UV radiation risk and exposure in children who take part in outdoor sports.

      OBJECTIVE: To evaluate the risk of developing UV radiation-induced skin lesions run by children who practise outdoor ...

      Known for Outdoor Sports | Uv Radiation | Skin Lesions | Sun Exposure | Minimal Erythema Dose
      KOL-Index: 8933

      BACKGROUND: Age of the patients and age of onset of psoriasis may have an impact on the disease. There is little information about psoriasis in elderly patients.

      OBJECTIVE: We evaluated epidemiological, clinical aspects, comorbidities and treatments of psoriasis in the elderly (>70 years) patients, and in patients with very late onset psoriasis (onset ≥ 70 years).

      METHODS: This observational multicentre non-interventional study of adults with psoriasis was conducted in 29 departments of ...

      Known for Onset Psoriasis | Elderly Patients | Clinical Aspects | Female France | Higher Frequency
      KOL-Index: 8610

      INTRODUCTION: Psoriasis is associated with a higher risk of cardiovascular and/or metabolic comorbidity in adults, but discordant data have been reported in children.

      OBJECTIVE: To evaluate the frequency of metabolic and cardiovascular comorbidity in children with psoriasis and to establish whether age at onset of psoriasis correlates with metabolic and cardiovascular comorbidity in adulthood.

      MATERIAL AND METHODS: We conducted a systematic review on MEDLINE, using PubMed and Ovid. The ...

      Known for Children Psoriasis | Obesity Hypertension | Metabolic Comorbidities | Cardiovascular Risk | Diseases Child
      KOL-Index: 8507

      Association of drug-induced hypersensitivity syndrome with viral infection is debated. Human herpesvirus 6 (HHV-6) reactivation has been the most frequently reported infection associated with this syndrome. However, a case of cytomegalovirus (CMV) infection was recently described associated with anticonvulsant-induced hypersensitivity syndrome. We report a case of severe allopurinol-induced hypersensitivity syndrome with pancreatitis associated with Epstein-Barr virus (EBV) infection. ...

      Known for Hypersensitivity Syndrome | Barr Virus | Ebv Infection | Hhv6 Dna | Drug Induced
      KOL-Index: 8352

      BACKGROUND/OBJECTIVES: Little information is available on the prevalence and clinical aspects of nail involvement in children with psoriasis. The objective of this study was to evaluate the prevalence and clinical aspects of and the risk factors for nail involvement in French children with psoriasis.

      METHODS: We performed a multicenter, cross-sectional study in 23 French dermatology centers. All children seen during the 1-year study were systematically included. Clinical features of the ...

      Known for Nail Psoriasis | 313 Children | Clinical Aspects | Psoriatic Arthritis | Background Objectives
      KOL-Index: 8209

      There is a known relationship between the use of immunosuppressive therapies and the development of lymphoproliferative malignancies. These lymphomas are mainly B-cell nonHodgkin's lymphomas associated with Epstein-Barr virus. Most cases concern classical immunosuppressive treatments including ciclosporin and methotrexate. A relationship between the new antitumour necrosis factor (TNF)-alpha agents and lymphoproliferative malignancies is debated. Patients with psoriasis on ...

      Known for Cell Lymphoma | Patients Psoriasis | Immunosuppressive Therapies | Lymphoproliferative Malignancies | Anti Tnf

      Key People For Children Psoriasis

      Top KOLs in the world
      Amy S Paller
      atopic dermatitis pediatric patients epidermolysis bullosa
      Matthias Augustin
      chronic wounds atopic dermatitis skin diseases
      Kristian Reich
      plaque psoriasis psoriatic arthritis monoclonal antibodies
      Alan M Menter
      psoriatic arthritis monoclonal antibodies patients psoriasis
      Enno Christophers
      atopic dermatitis human skin dermal fibroblasts
      Alice Bendix Gottlieb
      psoriatic arthritis monoclonal antibodies patients psoriasis

      Dermatology Department, Centre Hospitalier (CH), Argenteuil, France | Hôpital Victor Dupouy, Dermatologie, Argenteuil, France | Service de Dermatologie, Hôpital Victor Dupouy, Argenteuil, France | Department of Dermatology, Victor Dupouy Hospital, Ar

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.